H3K27 positive diffuse midline glioma. Report of one case

被引:0
|
作者
Araneda, Patricia [1 ]
Sujima, Emi [1 ,2 ]
Paredes-Manzo, Patricio [3 ]
Vallejo, Rodrigo [4 ]
Valdivia, Felipe [4 ]
Sinning, Mariana [1 ,2 ]
Gallegos, Marcela [5 ]
Fuller, Gregory [6 ]
机构
[1] Clin Alemana, Dept Neurol Psiquiatria, Santiago, Chile
[2] Clin Alemana, Dept Oncol, Santiago, Chile
[3] Clin Alemana, Dept Imagenol, Santiago, Chile
[4] Clin Alemana, Dept Cirugia, Santiago, Chile
[5] Clin Alemana, Dept Lab Clin, Banco Sangre & Anat Patol, Santiago, Chile
[6] MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA
关键词
Astrocytoma; Glioma; Histones;
D O I
10.4067/s0034-98872019001101487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 2016 WHO Classification of Tumours of the Central Nervous System incorporates a new diagnostic entity: the mutant diffuse midline glioma H3K27, a tumor with a characteristic location and special molecular biology. We report the case of a 51-year-old male patient with progressive diplopia. The imaging study showed a mesencephalic tumor; the stereotacic biopsy disclosed an Anaplastic Astrocytoma Isocitrate dehydrogenase (IDH) wild type. The molecular study concludes H3K27 mutation. The patient was treated with radiotherapy with concurrent and adjuvant chemotherapy (temozolomide) with partial recovery of the diplopia.
引用
收藏
页码:1487 / 1490
页数:4
相关论文
共 50 条
  • [1] Case report: an unusual long-term evolution of a diffuse midline glioma, H3K27 altered
    Griessmair, Michael
    Delbridge, Claire
    Zimmer, Claus
    Mayr, Eva
    Wagner, Arthur
    Canisius, Julian
    Metz, Marie-Christin
    Wiestler, Benedikt
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [2] H3K27M mutant diffuse midline glioma: a case report
    Luo, Y.
    Zeng, L.
    Xie, X-Q
    Wang, F.
    Liu, Y-Z
    Kang, J-B
    Li, X-F
    Wu, D-B
    Qu, B-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (05) : 2579 - 2584
  • [3] Targeting H3K27 Mutant Diffuse Midline Glioma Via Glucosylceramide Synthase Inhibitors
    Paret, C.
    Sandhoff, R.
    ElMalki, K.
    Wingerter, A.
    Zahnreich, S.
    Frauenknecht, K.
    Lehmann, N.
    Alexandra, R.
    Moisch, M.
    Faber, J.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S115 - S115
  • [4] Diffuse Midline Glioma, H3 K27M-Mutant: A Case Report
    Rodriguez Leon, Jose
    Perez Berenguer, Juan
    Morales Vargas, Bryan
    Rivera Roman, Keila
    Vigo Prieto, Juan
    Labat Alvarez, Eduardo
    Ferrer Torres, Luis
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S34 - S34
  • [5] Diffuse midline glioma H3K27M mutation in adult: A case report
    Bhattarai, Ayush Mohan
    Mainali, Gaurab
    Jha, Pinky
    Karki, Pearlbiga
    Adhikari, Abhishek
    Pandit, Ayushma
    Bhattarai, Ashish Mohan
    ANNALS OF MEDICINE AND SURGERY, 2022, 76
  • [6] Intraventricular H3K27-Altered Diffuse Midline Glioma in Lateral Ventricle: A Case Report
    Kwok, P. l
    Lui, Y. h
    Chin, H. k
    Ho, L. y
    Chan, S. k
    Chu, C. y
    HONG KONG JOURNAL OF RADIOLOGY, 2024, 27 (01): : e39 - e42
  • [7] A case of diffuse midline glioma, H3 K27M-mutant
    Kyriakopoulos, G.
    Anagnostopoulos, C.
    Boskos, C.
    Korfias, S.
    Stranjalis, G.
    Razis, E.
    Argyrakos, T.
    VIRCHOWS ARCHIV, 2017, 471 : S219 - S219
  • [8] Case N○1: Diffuse midline glioma, H3K27-altered
    Varlet, Pascale
    ANNALES DE PATHOLOGIE, 2022, 42 (05) : 383 - 385
  • [9] Positive H3K27M cytology in cerebrospinal fluid in diffuse midline glioma
    Kawai, Honami
    Hattori, Takaaki
    Nakajima, Yutaka
    Yokota, Takanori
    Onishi, Iichiroh
    NEUROLOGICAL SCIENCES, 2025, 46 (03) : 1451 - 1453
  • [10] GLUCOSYLCERAMIDE SYNTHASE INHIBITORS INDUCE CERAMIDE ACCUMULATION AND SENSITISE H3K27 MUTANT DIFFUSE MIDLINE GLIOMA TO IRRADIATION
    Paret, Claudia
    Sandhoff, Roger
    Zahnreich, Sebastian
    Wehling, Pia Charlotte
    El Malki, Khalifa
    Faber, Joerg
    NEURO-ONCOLOGY, 2022, 24 : 28 - 28